What patient characteristics would lead you to opt for triple therapy versus double therapy in newly diagnosed PAH?
Answer from: at Academic Institution
When treating patients with PAH it is essential to assess their mortality risk. Risk assessment is done using 2 tools that include the a) European Society of Cardiology/European Respiratory Society (ESC/ERS) guidelines (Comparative, Prospective Registry of Newly Initiated Therapies for Pulmonary Hyp...
Comments
at Cedars-Sinai Medical Center Thank you for this well articulated and cited answ...
at The Regents Of The University Of California I think that the short answer is: data are lacking...
at Cedars-Sinai Medical Center The 2022 ESC/ERS Guidelines for PH have shifted th...
Thank you for this well articulated and cited answ...
I think that the short answer is: data are lacking...
The 2022 ESC/ERS Guidelines for PH have shifted th...